SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001615774-18-003143
Filing Date
2018-05-01
Accepted
2018-05-01 17:26:34
Documents
8

Document Format Files

Seq Description Document Type Size
1 FORM S-3 s109856_s3.htm S-3 859375
2 EXHIBIT 1.02 s109856_ex1-02.htm EX-1.02 203277
3 EXHIBIT 5.1 s109856_ex5-1.htm EX-5.1 20517
4 EXHIBIT 5.02 s109856_ex5-02.htm EX-5.02 13655
5 EXHIBIT 23.1 s109856_ex23-1.htm EX-23.1 2469
6 GRAPHIC img001_v1.jpg GRAPHIC 11393
7 GRAPHIC img002_v1.jpg GRAPHIC 9212
8 GRAPHIC img003_v1.jpg GRAPHIC 4131
  Complete submission text file 0001615774-18-003143.txt   1134825
Mailing Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-224586 | Film No.: 18796645
SIC: 2834 Pharmaceutical Preparations